Dr. Michael J. Snyder received his medical degree from Louisiana State University in Shreveport, Louisiana, where he was admitted into the Alpha Omega Alpha Honor Medical Society. He then went on to finish his general surgery internship and residency at Tripler Army Medical Center in Hawaii. Following a deployment to Turkey to lead a medical clinic and duty in the US Army during Operation Desert Shield and Desert Storm, he finished his fellowship in colon and rectal surgery at McGovern Medical School at UTHealth in Houston.
Dr. Snyder believes in treating his patients with compassion and care. He employs cutting-edge technologies and takes the necessary time with each patient to ensure that they are comfortable and understand their situation.
Dr. Snyder is a member of various medical associations and the current president of the Texas Society of Colon and Rectal Surgeons. He has authored several medical publications and given several scholarly lectures.
Dr. Snyder has served as president of the Texas Society of Colon and Rectal Surgeons and as a member of the Colon and Rectal Surgery Residency Review Committee. He is now the chairman of the Harris County Medical Society’s Board of Socioeconomics.
He has written or co-written several book chapters, submitted numerous papers to peer-reviewed magazines, and presented his work at local and national conferences. He has co-authored two books, ‘Wallach’s Interpretation of Diagnostic Tests’ and ‘Get Prepared Now!: Why A Great Crisis Is Coming & How You Can Survive It’.
Inspiring Talks by Dr. Michael Synder
- “Another example is tamoxifen, which is used for the treatment of endocrine responsive breast cancer. Tamoxifen is given to patients post-surgery and dramatically reduces the rate of cancer recurrence. This drug is metabolized by cytochrome P450 2D6, the product of the CYP2D6 gene. Based on their DNA, there are patients with little CYP2D6 activity who are poor metabolizers and others with high activity who are extensive metabolizers.”
- “In the above examples, a sample of the tumor (e.g., biopsy) is tested to determine the molecular signature. Testing may be by genetic sequence tests (e.g., for BCR-ABL, mutated EGFR, or HER2 gene amplification) or tissue protein stains (e.g., for the presence of ER/PR receptors or HER2 protein overexpression). The results of the testing will guide the choice of treatment—it will be personalized for the individual.”
- “All of a sudden, really crazy things are starting to happen all over the world. Giant swarms of locusts are absolutely devastating entire regions, extremely unusual storms are confounding meteorologists, earthquake and volcanic activity are both on the rise, and five very dangerous diseases are sweeping across the globe.”
- “I learn your ear skin grows from the inside out, taking wax with it. Pretty cool.”
- “Our paper on using Smart Watches for Real-Time Alerting for COVID and other stressors is out. Scalable to the whole planet. “
- “Our wearable devices have the potential to be powerful tools for detecting viral illness. “
- “One-third of the U.S. population has prediabetes with 9 out of 10 people unaware.”
- “Excited by the progress made to bring non-invasive whole-body scanning to everyone. This builds on our belief in the science of medicine, precision medicine, and having your own personal baselines to proactively track changes in health.”
- “Our COVID-19 early detection Phase I publication has received noticeable attention in a short 3 months.”
- “New techs let you measure thousands of health parameters that can be collected in a proactive healthcare system. Focusing on comprehensive health data to keep individuals healthy….”